The practical management of refractory schizophrenia - the Maudsley Treatment REview and Assessment Team service approach

Practitioner attitudes to clozapine initiation

(2013) S. Gee et al.   ACTA PSYCHIATRICA SCANDINAVICA

The social and economic burden of treatment-resistant schizophrenia

(2013) James L. Kennedy et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Termination of Clozapine Treatment Due to Medical Reasons

(2013) Jimmi Nielsen et al.   JOURNAL OF CLINICAL PSYCHIATRY

Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation

(2012) Oliver D. Howes et al.   BRITISH JOURNAL OF PSYCHIATRY

A systematic review of the evidence of clozapine's anti-aggressive effects

(2012) Catherine Frogley et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Optimizing clozapine treatment

(2011) J. Nielsen et al.   ACTA PSYCHIATRICA SCANDINAVICA

A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for Schizophrenia

(2011) Jari Tiihonen et al.   AMERICAN JOURNAL OF PSYCHIATRY

Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology

(2011) Thomas RE Barnes et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study

(2011) Maria Rosaria A. Muscatello et al.   SCHIZOPHRENIA RESEARCH

Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial

(2010) W. Wolfgang Fleischhacker et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Effectiveness of Medications Used to Attenuate Antipsychotic-Related Weight Gain and Metabolic Abnormalities: A Systematic Review and Meta-Analysis

(2010) Lawrence Maayan et al.   NEUROPSYCHOPHARMACOLOGY

Plasma Clozapine, Norclozapine, and the Clozapine:Norclozapine Ratio in Relation to Prescribed Dose and Other Factors: Data From a Therapeutic Drug Monitoring Service, 1993–2007

(2010) Lewis Couchman et al.   THERAPEUTIC DRUG MONITORING

β-Adrenergic Antagonists for the Treatment of Clozapine-Induced Sinus Tachycardia

(2009) Rafael Stryjer et al.   CLINICAL NEUROPHARMACOLOGY

A Randomized, Double-Blind Comparison of Clozapine and High-Dose Olanzapine in Treatment-Resistant Patients With Schizophrenia

(2009) Herbert Y. Meltzer et al.   JOURNAL OF CLINICAL PSYCHIATRY

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)

(2009) Jari Tiihonen et al.   LANCET

The efficacy of lamotrigine in clozapine-resistant schizophrenia: A systematic review and meta-analysis

(2009) Jari Tiihonen et al.   SCHIZOPHRENIA RESEARCH

The metabolic syndrome and schizophrenia

(2008) J. M. Meyer et al.   ACTA PSYCHIATRICA SCANDINAVICA

Life-Threatening Constipation Associated with Clozapine

(2008) Sanil Rege et al.   Australasian Psychiatry

Amisulpride Augmentation in Patients with Schizophrenia Partially Responsive or Unresponsive to Clozapine. A Randomized, Double-Blind, Placebo-Controlled Trial

(2008) H.-J. Assion et al.   PHARMACOPSYCHIATRY

Combined antipsychotic treatment involving clozapine and aripiprazole

(2008) Susanne Englisch et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY